HJB - Your Trusted Biologics CDMO Partner
HJB, CDMO, biologics, HJB Bio, hjbbio, China CDMO, 杭州奕安济世, Just Bio, Just biotherapeutics, HJB bio, HJB China, Hangzhou HJB
Want to know how HJB get from DNA to IND in just 12 to 15 months? Come check out the upcoming webinar at 11 AM to 12PM EDT on April 30, provided by Cambridge Healthcare Institute!
With the topic of Fast CMC Development from DNA to IND, our Sr. Director Global CMC operations Dr. Van Leang and General Manager of CDMO Business Unit Dr. Jerry Yang will present HJB’s approach of parallel process development and fast to final clone and tox material. This approach can save 2-3 months from a typical timeline.
We will also discuss the regulatory requirement for a large molecule CMC package in IND filing and how those requirement affect the overall timeline and strategy selecting a CDMO for a novel therapeutic molecule.
Register for free now at: http://www.healthtech.com/hjb-fast-cmc-development/